Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Commercial Insight: Antihormonal Cancer Therapies' returned 4 results - Page 1 of 1  FEATURED RESULTS Cancer Diagnostic Testing World Markets Antibody Drug Target Atlas in Oncology Drug Delivery in Cancer - Technologies, Markets and Companies Skin Cancer Lung Cancer, 3rd Edition   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Commercial Insight: Antihormonal Cancer Therapies - Leading brands strive to minimize generic sales erosion   Datamonitor, July 2010, Pages: 111 pharmaceutical markets, 2010-2019 List of Figures Figure 26: Methodology for forecasting price to remove impact of currency fluctuations on future trend Commercial Insight: Antihormonal Cancer Therapies Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019   Datamonitor, Aug 2010, Pages: 132 Figure 26: Methodology for forecasting price to remove impact of currency fluctuations on future trend Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types   Datamonitor, Sep 2008, Pages: 287 investigating adjuvant Reniale 250 Figure 65: Datamonitor drug assessment summary of pipeline molecular targeted therapies in development for hematological malignancies, 2007 283 Pipeline Insight: Cancer Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid   Datamonitor, July 2008, Pages: 328 for radioiodine therapy 262 Figure 78: Datamonitor drug assessment summary of pipeline molecular targeted therapies in development for hematological malignancies, 2007 297 Pipeline Insight: Cancer Overview Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network